Shares to Watch: Zomato, Nykaa, Hero MotoCorp, RIL, Godrej Properties, and extra

Right here’s a fast have a look at shares more likely to be in focus in immediately’s commerce.

Zomato: World brokerage Morgan Stanley has expressed a bullish view on Zomato, growing its goal value to ₹355 from the earlier ₹278. This revision implies a possible upside of 31.7% from the inventory’s latest closing value. The agency maintained an ‘obese’ ranking, citing optimism in Zomato’s fast commerce (QC) phase, which it famous may exceed market expectations and drive future development.

Hero MotoCorp: Hero MotoCorp reported a consolidated revenue after tax of ₹1,066 crore for the quarter ending September 30, 2024, reflecting a 6% year-on-year enhance. The expansion was attributed to robust gross sales efficiency, as income from operations rose to ₹10,483 crore, in comparison with ₹9,533 crore in the identical quarter final yr. The corporate bought 15.2 lakh models of bikes and scooters throughout this era, surpassing the 14.16 lakh models bought within the earlier yr.

Godrej Properties: Godrej Properties has refuted allegations of fraud and cash laundering, terming them “baseless” and attributing the claims to a dispute with a dissatisfied three way partnership companion. The corporate’s assertion got here in response to the continuing Enforcement Directorate (ED) investigation tied to a housing challenge.

Reliance Industries: RIL, Viacom 18 Media Non-public Restricted, and The Walt Disney Firm introduced the completion of their anticipated merger. The ensuing three way partnership, valued at ₹70,352 crore, goals to strengthen its place as considered one of India’s largest media and leisure entities. Reliance has invested ₹11,500 crore as development capital. This merger is anticipated to assist expansions in digital content material, broadcasting, and distribution.

Grasim Industries: Grasim reported a 66% decline in consolidated web revenue to ₹390 crore for Q2FY25, down from ₹1,164 crore in the identical quarter final yr. The drop was attributed to decrease cement gross sales and ongoing investments in its paints enterprise underneath the Birla Opus model. Nonetheless, income rose by 11.1% year-on-year to ₹33,562.85 crore, bolstered by positive aspects in monetary companies, cellulosic staple fiber, and specialty chemical substances.

PTC Industries: PTC Industries posted a web revenue of ₹17.31 crore for Q2FY25, greater than doubling the ₹8.14 crore reported within the corresponding quarter of the earlier fiscal yr. The corporate’s income from operations additionally confirmed a considerable rise, reaching ₹72.36 crore in comparison with ₹57.51 crore in the identical interval final yr.

Happiest Minds: Happiest Minds Applied sciences reported a web revenue of ₹50 crore for Q2FY25, down 3% from the earlier quarter’s ₹51 crore. Nonetheless, the corporate’s income elevated by 12% quarter-on-quarter to ₹522 crore, up from ₹464 crore within the June-ended quarter. The working margin stood at 13.2%, whereas income in fixed forex phrases rose 7% sequentially and 28.2% year-on-year. The board declared an interim dividend of ₹2 per share.

Sobha Ltd: Sobha reported a revenue after tax of ₹26.1 crore for Q2FY25, displaying a 3.3-fold enhance quarter-on-quarter and a 74% rise year-on-year. Web revenues have been recorded at ₹965 crore, marking a 44% development QoQ and a 25% rise YoY. The corporate’s actual property collections in the course of the quarter reached ₹1,222 crore, indicating robust money circulation.

Honasa Shopper: Nykaa reported a consolidated web lack of ₹19 crore for Q2FY25, contrasting with a revenue of ₹29 crore in the identical quarter final yr. The decline was attributed to a one-time stock correction amid modifications in its distribution mannequin. Income from operations fell by 7% to ₹462 crore in comparison with ₹496 crore within the year-ago interval.

Delhivery: Delhivery posted a consolidated web revenue of ₹10 crore for Q2FY25, reversing a lack of ₹103 crore in the identical interval final yr. Nonetheless, the revenue dropped by 81% from the ₹54 crore recorded within the June-ended quarter. Income from operations grew by 13% to ₹2,190 crore from ₹1,942 crore within the earlier fiscal yr.

Glenmark Prescription drugs: Glenmark Pharma reported a web revenue of ₹340 crore for Q2FY25, a major turnaround from a web lack of ₹180 crore within the corresponding quarter final yr. Income for the quarter rose by 7% year-on-year to ₹3,434 crore. EBITDA elevated by 30.2% YoY to ₹602 crore, with margins bettering to 17.5%.